- 全部删除
您的购物车当前为空
HSD17B13-IN-5 (Compound 96) 是一种针对羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的抑制剂,对雌二醇底物 LCMS 的 Ki 值为 ≤ 50 nM。HSD17B13-IN-5 适用于研究如 NAFLD、NASH 或药物性肝损伤 (DILI) 等肝病,以及代谢性疾病或心血管疾病。
HSD17B13-IN-5 (Compound 96) 是一种针对羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的抑制剂,对雌二醇底物 LCMS 的 Ki 值为 ≤ 50 nM。HSD17B13-IN-5 适用于研究如 NAFLD、NASH 或药物性肝损伤 (DILI) 等肝病,以及代谢性疾病或心血管疾病。

HSD17B13-IN-5 相关产品
| 产品描述 | HSD17B13-IN-5 (Compound 96) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with a Ki value of ≤ 50 nM for the estradiol substrate LCMS. It is applicable in research on liver diseases, metabolic disorders, or cardiovascular conditions, such as NAFLD or NASH, or drug-induced liver injury (DILI). |
| 分子式 | C26H15ClF4N4O3S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容